Have a feature idea you'd love to see implemented?
Let us know!
GKOS GLAUKOS Corp
Price (delayed)
$151.22
Market cap
$8.34B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.96
Enterprise value
$8.39B
Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery,
Highlights
The debt has shrunk by 59% YoY
GLAUKOS's equity has increased by 40% YoY
GLAUKOS's net income has decreased by 16% YoY but it has increased by 6% QoQ
GLAUKOS's EPS has decreased by 10% YoY but it has increased by 8% from the previous quarter
The quick ratio has contracted by 12% YoY
Key stats
What are the main financial stats of GKOS
Market
Valuations
Earnings
Shares outstanding
55.14M
Market cap
$8.34B
Enterprise value
$8.39B
Price to earnings (P/E)
N/A
Price to book (P/B)
12.43
Price to sales (P/S)
23.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.28
Revenue
$360.35M
Gross profit
$276.06M
Net income
-$149.57M
EBIT
-$136.73M
EBITDA
-$97M
Free cash flow
-$81.23M
Per share
Balance sheet
Liquidity
EPS
-$2.96
EPS diluted
-$2.96
Free cash flow per share
-$1.48
Book value per share
$12.17
Revenue per share
$6.55
TBVPS
$10.74
Total assets
$926.54M
Total liabilities
$258.03M
Debt
$157.13M
Equity
$668.51M
Working capital
$325.6M
Debt to equity
0.24
Current ratio
5.54
Quick ratio
4.51
Net debt/EBITDA
-0.54
Margins
Efficiency
Dividend
EBITDA margin
-26.9%
Gross margin
76.6%
Net margin
-41.5%
Operating margin
-36.7%
Return on assets
-16.1%
Return on equity
-26.6%
Return on invested capital
-19.4%
Return on capital employed
-16%
Return on sales
-37.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GKOS stock price
How has the GLAUKOS stock price performed over time
Intraday
1.93%
1 week
3.33%
1 month
5.01%
1 year
83.65%
YTD
90.24%
QTD
16.07%
Financial performance
How have GLAUKOS's revenue and profit performed over time
Revenue
$360.35M
Gross profit
$276.06M
Operating income
-$132.32M
Net income
-$149.57M
Gross margin
76.6%
Net margin
-41.5%
The company's gross profit rose by 20% YoY and by 6% QoQ
The revenue has grown by 19% YoY and by 5% from the previous quarter
GLAUKOS's net income has decreased by 16% YoY but it has increased by 6% QoQ
The net margin has increased by 11% QoQ and by 2.6% YoY
Growth
What is GLAUKOS's growth rate over time
Valuation
What is GLAUKOS stock price valuation
P/E
N/A
P/B
12.43
P/S
23.1
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
23.28
GLAUKOS's EPS has decreased by 10% YoY but it has increased by 8% from the previous quarter
The price to book (P/B) is 122% more than the 5-year quarterly average of 5.6 and 29% more than the last 4 quarters average of 9.6
GLAUKOS's equity has increased by 40% YoY
The P/S is 110% higher than the 5-year quarterly average of 11.0 and 44% higher than the last 4 quarters average of 16.0
The revenue has grown by 19% YoY and by 5% from the previous quarter
Efficiency
How efficient is GLAUKOS business performance
The ROIC is down by 39% year-on-year and by 2.1% since the previous quarter
The return on assets has declined by 21% year-on-year but it is up by 5% since the previous quarter
The ROE has grown by 14% from the previous quarter but it has contracted by 3.1% YoY
GLAUKOS's ROS has increased by 10% from the previous quarter
Dividends
What is GKOS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GKOS.
Financial health
How did GLAUKOS financials performed over time
The company's total liabilities fell by 45% YoY
The quick ratio has contracted by 12% YoY
The debt is 76% lower than the equity
The debt to equity has plunged by 70% YoY
The debt has shrunk by 59% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.